LncRNA GAS5 Overexpression Reverses LPS-Induced Inflammatory Injury and Apoptosis Through Up-Regulating KLF2 Expression in ATDC5 Chondrocytes

Cell Physiol Biochem. 2018;45(3):1241-1251. doi: 10.1159/000487455. Epub 2018 Feb 9.

Abstract

Background/aims: Osteoarthritis (OA) is the most frequently occurring joint disease and characterized by degeneration of cartilage. As the unique cell type in cartilage, chondrocytes play a crucial role during OA. Our study explored the influence of long non-coding RNA (lncRNA) growth arrest-specific transcript 5 (GAS5) on lipopolysaccharides (LPS)-induced injury in ATDC5 cells.

Methods: Cell viability, apoptosis and expression of inflammatory cytokines were all assessed to evaluate LPS-induce inflammatory injury. Expression of GAS5 in LPS-induced cells was evaluated by qRT-PCR. After cell transfection, effect of abnormally expressed GAS5 on LPS-induced inflammatory injury was determined. Then, the possible target of GAS5 was screened by bioinformatics and verified by qRT-PCR and luciferase activity assay. Together, whether aberrant expression of target gene affected the modulation of GAS5 in LPS-induced inflammatory injury was also assessed. Finally, the influences of aberrant expressed Kruppel-like factor 2 (KLF2) on nuclear factor κB (NF-κB) and Notch pathways were detected by Western blot analysis.

Results: LPS reduced cell viability and promoted cell apoptosis and secretion of inflammatory cytokines, along with down-regulation of GAS5. LPS-induced injury was alleviated by GAS5 overexpression while was exacerbated by GAS5 silence. KLF2 was predicted and verified as a target of GAS5, and GAS5 functioned through regulating expression of KLF2. Besides, aberrant expression of KLF2 regulated expressions of key kinases involved in the NF-κB and Notch pathways.

Conclusion: GAS5 might ameliorate LPS-induced inflammatory injury in ATDC5 chondrocytes by inhibiting the NF-κB and Notch signaling pathways.

Keywords: Kruppel-like factor 2; LPS-induced injury; LncRNA GAS5; NF-κB and Notch pathways; Osteoarthritis.

Publication types

  • Retracted Publication

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Cell Line
  • Chondrocytes / cytology
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism
  • Down-Regulation / drug effects
  • Humans
  • Interleukin-1beta / analysis
  • Interleukin-6 / analysis
  • Interleukin-8 / analysis
  • Kruppel-Like Transcription Factors / genetics*
  • Kruppel-Like Transcription Factors / metabolism
  • Lipopolysaccharides / toxicity*
  • Mice
  • NF-kappa B / metabolism
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*
  • Receptors, Notch / metabolism
  • Tumor Necrosis Factor-alpha / analysis
  • Up-Regulation / drug effects*

Substances

  • Interleukin-1beta
  • Interleukin-6
  • Interleukin-8
  • Klf2 protein, mouse
  • Kruppel-Like Transcription Factors
  • Lipopolysaccharides
  • NF-kappa B
  • RNA, Long Noncoding
  • Receptors, Notch
  • Tumor Necrosis Factor-alpha
  • long non-coding RNA GAS5, mouse